Coreceptor control of T cell cross-reactivity. (360G-Wellcome-079848_Z_06_Z)
T cells recognise foreign' peptide fragments, in the context of self' major histocompatibility complex (MHC) molecules on the surface of host cells. Recognition orchestrates the immune response to protect against pathogen attack. The detection of T-cell antigens is unique inreceptor recognition because it involves the binding of both receptor (T-cell receptor; TCR) and coreceptor (CD8 or CD4). The TCR is also unique in that it must cross-react with > 106 different peptide antigens to ensure complete coverage of the array of possible permutations generated from 20 amino acid residues. This inherent cross-reactivity requires precise developmental regulation to ensure that the peripheral T-cell repertoire is optimally poised to respond in the face ofT cells recognise foreign' peptide fragments, in the context of self' major histocompatibility complex (MHC) molecules on the surface of host cells. Recognition orchestrates the immune response to protect against pathogen attack. The detection of T-cell antigens is unique inreceptor recognition because it involves the binding of both receptor (T-cell receptor; TCR) and coreceptor (CD8 or CD4). The TCR is also unique in that it must cross-react with > 106 different peptide antigens to ensure complete coverage of the array of possible permutations generated from 20 amino acid residues. This inherent cross-reactivity requires precise developmental regulation to ensure that the peripheral T-cell repertoire is optimally poised to respond in the face ofdanger while remaining continuously quiescent in the presence of self. Preliminary data indicate thatthe coreceptor controls and optimizes T-cell cross-reactivity. I will use a combinatorial peptide library approach and mutant MHC molecules that exhibit > 1000-fold range of coreceptor binding whilemaintaining faithful TCR interactions to: Assess how the coreceptors influence T-cell cross-reactivity Examine the role of CD8 sialylation in cross-reactivity Assess coreceptor-mediated T cell cross-reactivity in different species. This work has potentially important implications for our understanding of autoimmunity and could inform therapeutic interventions.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 633868 |
Applicant Surname | Wooldridge |
Approval Committee | Clinical Interview Committee |
Award Date | 2006-07-12T00:00:00+00:00 |
Financial Year | 2005/06 |
Grant Programme: Title | Intermediate Clinical Fellowship |
Internal ID | 079848/Z/06/Z |
Lead Applicant | Prof Linda Wooldridge |
Partnership Value | 633868 |
Planned Dates: End Date | 2013-08-31T00:00:00+00:00 |
Planned Dates: Start Date | 2006-11-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | Wales |
Sponsor(s) | Prof Paul Morgan |